Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Latam HQ Health is a pharmaceutical commercialization and distribution company headquartered in the United Kingdom, specifically focused on the Latin American market. Established in 2015, the company acts as a strategic gateway for international healthcare firms seeking to enter Central and South America by providing regulatory support, market access, and distribution services. A primary component of its business is its partnership with the Italian firm BMG Pharma, for which it handles the registration and launch of specialized dermatological products. Its portfolio includes products such as IaluXid, a topical gel used for the treatment of acne and skin infections. The company operates across multiple sectors, including pharmaceuticals, medical devices, and cosmetics. By leveraging its expertise in regional regulations, Latam HQ Health facilitates the expansion of European healthcare innovations into emerging markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Latam HQ Health.